To support the public's right to know therapeutically relevant information as soon as possible, we reduced the time for authors to revise their manuscripts to 30 days. Our goal for 2013 is to reduce our current 91 days from acceptance to publication of a manuscript to 60 days. Rapid review of manuscripts depends on a dedicated editorial board with the assistance of many colleagues. To support the quickened pace of review, we have recently changed the leadership of our editorial board. We wish to welcome the following new members of the editorial board: April W. Armstrong, MD, MPH, Jeremy S. Bordeaux, MD, MPH, Ashfaq A. Marghoob, MD, Cindy England Owen, MD, and Julie V. Schaffer, MD. We rely on the members of the editorial board to assist in editorial decisions when their expertise is particularly relevant. While JAMA Dermatology evolves by using technology to meet the needs of dermatologists and our patients with skin diseases, we will endeavor to remain your “go-to source” of information concerning the skin, its diseases, and their treatment, which has been the first sentence of our mission statement for 16 years. Although the name changes, our mission remains steadfastly the same.